Overview This page contains the latest trade data of Vaccines, human use. In 2021, Vaccines, human use were the world's 16th most traded product, with a total trade of $115B. Between 2020 and 2021 the exports of Vaccines, human use grew by 253%, from $32.7B to $115B. Trade in Vaccines, human use represent 0.55% of total world trade.
Vaccines, human use are a part of Vaccines, blood, antisera, toxins and cultures.
Exports In 2021 the top exporters of Vaccines, human use were Belgium ($36B), China ($15.4B), United States ($14.2B), Germany ($11.8B), and Spain ($6.79B).
Imports In 2021 the top importers of Vaccines, human use were Belgium ($13.5B), Germany ($10.3B), United States ($8.58B), Spain ($7.24B), and Japan ($5.55B).
Tariffs In 2018 the average tariff for Vaccines, human use was 0.86%, making it the 6418th lowest tariff using the HS6 product classification.
Ranking Vaccines, human use ranks 297th in the Product Complexity Index (PCI).
Description A vaccine is a substance that creates immunity against a disease. It is typically administered by injection, but may be administered orally or by aerosol. Vaccines can protect against many infectious diseases including measles, mumps, tetanus, polio, rubella, and hepatitis A.